Status:
COMPLETED
Bright Light Therapy on Post-stroke Insomniawith Post-stroke Insomnia
Lead Sponsor:
Inha University Hospital
Conditions:
Stroke Sequelae
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of this study was to determine the effectiveness of bright light therapy as a treatment for early, mild-to-moderate stroke patients with post-stroke insomnia.
Eligibility Criteria
Inclusion
- first occurrence of stroke for the patient
- matched International Classification of Diseases (ICD)-10 codes (nontraumatic subarachnoid hemorrhage \[I60\], nontraumatic intracerebral hemorrhage \[I61\], other and unspecified nontraumatic intracranial hemorrhage \[I62\], or cerebral infarction \[I63\]) (World Health Organization, 1997)
- mild-to-moderate stroke (the National Institutes of Health Stroke Scale ≤14)
- age ≥18 years
- satisfactory cognitive function
- post-stroke insomnia.
Exclusion
- Mini Mental State Examination (MMSE) score of ≤10
- recurrent stroke
- aphasia
- transient ischemic attack
- schizophrenia, bipolar disorder, mood disorder, previous insomnia disorder, or dementia before stroke
- taking sleeping pills or antidepressants for 5 or more days within a 6-month timespan before the onset of stroke
- post-stroke delirium
- a National Institutes of Health Stroke Scale score ≥ 14
- previous eye disease or post-stroke eye disease
- severe auditory impairment
- the use of psychotropic medications (hypnotics, benzodiazepine, benzodiazepine agonists, antidepressants \[mirtazapine or trazodone\] or antipsychotics)
Key Trial Info
Start Date :
August 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2018
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT04721574
Start Date
August 1 2016
End Date
August 1 2018
Last Update
January 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Inha university hospital
Incheon, Jung-Gu, South Korea, 22332